Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Prophin is a biotechnology company specializing in the development and production of high-quality recombinant proteins and peptides for research and therapeutic applications. The company leverages proprietary expression systems to optimize the yield and purity of complex biological molecules, serving as a critical partner for pharmaceutical and academic researchers. Prophin's core business includes contract manufacturing and the supply of specialized reagents used in drug discovery and diagnostic development. By focusing on scalable production technologies, the company aims to accelerate the transition of biological candidates from the laboratory to clinical evaluation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prophin.